GRCE · Grace Therapeutics, Inc.
$2.20
+0.06 (+2.80%)
At close · Aug 21
Market Cap
$46.28M
Shares
21.04M
Grace Therapeutics, Inc. Earnings Call Transcripts
Every quarterly earnings call for Grace Therapeutics, Inc. (GRCE) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Annual General Meeting
Investor event
2026-09-17
Annual Meeting of Shareholders
Scheduled
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY23 · Q3
2023-02-14
Grace Therapeutics, Inc. Q3 FY2023 Earnings Call
Diluted EPS
$-0.52
Rev · 2q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2022-11-14
Grace Therapeutics, Inc. Q2 FY2023 Earnings Call
Diluted EPS
$-0.66
Rev · 2q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2022-08-11
Grace Therapeutics, Inc. Q1 FY2023 Earnings Call
Diluted EPS
$-0.61
Rev · 2q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2022-06-21
Grace Therapeutics, Inc. Q4 FY2022 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-02-14
Grace Therapeutics, Inc. Q3 FY2022 Earnings Call
Revenue
$
▼ 100% YoY Diluted EPS
$-0.54
Rev · 2q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2021-11-10
Grace Therapeutics, Inc. Q2 FY2022 Earnings Call
Diluted EPS
$-0.18
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2021-08-12
Grace Therapeutics, Inc. Q1 FY2022 Earnings Call
Diluted EPS
$-0.72
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2021-06-22
Grace Therapeutics, Inc. Q4 FY2021 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q1
2020-08-13
Grace Therapeutics, Inc. Q1 FY2021 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2020-06-29
Grace Therapeutics, Inc. Q4 FY2020 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Showing 1–11 of 11 earnings calls
Key facts
CIK
1444192
CUSIP
00439U104
13F (30d)
33 filings
33 filers
Visit website
Investor relations